Emisphere Technologies, Inc. clinical trials
Acquired by Novo Nordisk A/S, Dec 8, 2020 · source ↗
The registry lists 2 studies whose lead sponsor is Emisphere Technologies, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 11, 2011.
Before and after it joined Novo Nordisk A/S
- First submitted before Emisphere Technologies, Inc. became part of Novo Nordisk A/S
- 2
- First submitted after Emisphere Technologies, Inc. became part of Novo Nordisk A/S
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Status
- Completed
- 2
Registry sponsor names on this page
- Emisphere Technologies, Inc.2 studies
Something wrong with this grouping? Tell us on the Novo Nordisk A/S page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Novo Nordisk A/S studies →
- Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum CobalaminCompletedNCT01312831Not applicable
Sponsor listed in the registry: Emisphere Technologies, Inc. · First submitted before Emisphere Technologies, Inc. became part of Novo Nordisk A/S
- Oral Cyanocobalamin (Eligen B12) Bioavailability StudyCompletedNCT01311739Not applicable
Sponsor listed in the registry: Emisphere Technologies, Inc. · First submitted before Emisphere Technologies, Inc. became part of Novo Nordisk A/S